Connect Life Sciences Appoints Megan Driscoll - Jun 1

The Story

Connect Life Sciences announced on June 1, 2026 that Megan Driscoll has been appointed Executive Chairman of its Board of Directors. The company is a life sciences recruitment firm and a portfolio company of Argosy Healthcare Partners.

Why It Matters For Your Portfolio

• Leadership change effective Jun 1, 2026, could shift strategic priorities at Connect Life Sciences, potentially influencing growth or M&A plans.
• Connect Life Sciences is privately held by Argosy Healthcare Partners, so there is no public share price or disclosed revenue for you to track directly.
• The company lists operations tied to Wayne, Pennsylvania and Orlando, Florida, indicating at least 2 operational hubs that may be targeted for expansion or integration.
• Private-equity backing means any material value events for investors will likely come through AHP disclosures or transactional announcements, not routine public filings.

The Trade

This update is most relevant to private equity watchers, healthcare staffing investors and anyone tracking strategic hires in life sciences recruitment. Watch for follow-up disclosures from Argosy Healthcare Partners and Connect Life Sciences for details on strategy, staffing changes, or any transaction announcements. Want to track impact, monitor AHP communications and future press releases from Connect Life Sciences.